The rate of deaths from ischemic heart disease related to obesity nearly tripled in the U.S. over a two-decade span, ...

Danish biotech Gubra A/S said its experimental obesity drug showed weight loss and mild side effects in a small study, ...

Vitamin D supplementation may help manage hypertension, particularly in older adults with overweight or obesity, a new study ...

Lives lost to obesity-related heart disease have nearly tripled over the past twenty years, a new study reports.

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September, and according to ...

Gubra’s once-weekly obesity candidate was tied to 3% weight loss during a six-week phase 1 trial, with a single injection ...

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...

On Tuesday, a tiny shred of data on Amgen’s lead obesity candidate — not yet verified — erased $12 billion in market value.

A new study found that popular weight loss and obesity drugs, Ozempic and Wegovy can help people cut back on drinking. The ...

Adults With Obesity More Likely to Ration Drugs to Save Money. Adults with obesity are more likely to ration their ...

Despite the diverse nature of obesity, there is compelling genetic, clinical, and experimental evidence that endorses the ...